Hunan Jiudian Pharmaceutical Co., Ltd.

XSEC:300705 Stock Report

Market Cap: CN¥11.5b

Hunan Jiudian Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Hunan Jiudian Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥367.3M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are CN¥3.2B and CN¥857.7M respectively. Hunan Jiudian Pharmaceutical's EBIT is CN¥537.7M making its interest coverage ratio 44.8. It has cash and short-term investments of CN¥710.0M.

Key information

15.4%

Debt to equity ratio

CN¥367.34m

Debt

Interest coverage ratio44.8x
CashCN¥710.04m
EquityCN¥2.38b
Total liabilitiesCN¥857.67m
Total assetsCN¥3.24b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300705's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥377.7M).

Long Term Liabilities: 300705's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥479.9M).


Debt to Equity History and Analysis

Debt Level: 300705 has more cash than its total debt.

Reducing Debt: 300705's debt to equity ratio has reduced from 17% to 15.4% over the past 5 years.

Debt Coverage: 300705's debt is well covered by operating cash flow (175.8%).

Interest Coverage: 300705's interest payments on its debt are well covered by EBIT (44.8x coverage).


Balance Sheet


Discover healthy companies